Inluriyo (imlunestrant)
200 mg/1 · Film-Coated Tablet
By Eli Lilly and Company
- NDC
- 0002-1717
- Route
- Oral
- Therapeutic class
- Breast Cancer Resistance Protein Inhibitors [MoA], Estrogen Receptor Antagonist , Estrogen Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 28 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28)NDC 0002-1717-28Available to order
- 56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-56)NDC 0002-1717-56Available to order
- 56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-61)NDC 0002-1717-61Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Diabetes & Endocrine
See all →
OMEOSPORT
Pellet
Guna spa
Available to source

GUNA-GERIATRICS
Solution / Drops
Guna spa
Available to source

PROCORT (1.85% hydrocortisone acetate - 1.15% pramoxine hci cream)
18.5 mg/g / 11.5 mg/g · Cream
Womens Choice Pharmaceuticals LLC
Available to source

Equate Hydrocortione (1% Hydrocortisone)
10 mg/g · Cream
Walmart Inc.
Available to source
